The Applied Parkinson’s Research Group, led by Dr Camille Carroll, oversees the clinical trials and studies aimed at improving the lives of those with Parkinson’s through neuroprotective interventions, digital innovation for care and research and genetic aspects of Parkinson’s.
Intrinsic to their work is the person-centred care approach. Dr Carroll and her team collaborate with an engaged and eternally optimistic community of Parkinson’s patients.
Engaging with them from the beginning, they provide research and health interventions that challenge the ‘status quo’ bio-medical approach to treating the illness and place as much control and influence over decisions on health and care in the hands of patients, care partners, and the community. These co-designed pathways provide choices to patients and treatments that are sustainable in the long-run.
Dr Camille Carroll has overseen the development of a Parkinson’s diseases (PD) DNA bank and a regional PD clinical research register, as well as leading the development of the Parkinson’s disease service in Plymouth – the winner of two Parkinson’s Excellence Network Awards.